Tonutti E, Sala P, Feruglio C, Yin Z, Colombatti A
Istituto di Chimica Clinica, Ospedale S. Maria della Misericordia, Udine, Italy.
Clin Immunol Immunopathol. 1994 Dec;73(3):312-20. doi: 10.1006/clin.1994.1204.
A group of 18 individuals is described that manifest persistent (follow up between 4 and 57 months) expansions (ranging from 10 to 70%) of CD4+ CD8+ peripheral T cells. In nine individuals there was no apparent underlying disease whereas the remaining displayed a wide range of unrelated diseases. Analysis of the cell surface immunophenotype showed that all individuals express high densities of CD2, CD3, CD5, and TCR alpha/beta on their CD4+ CD8+ subset. On the contrary, these cells did not express CD25, CD38, CD71, HLA-DR, and the beta chain of the interleukin-2 receptor (p75) but expressed high density of CD29 and low density or absence of CD7. CD8 was "dim" in most individuals and consisted only of the CD8 alpha chain isoform. These individuals could be further divided into two subgroups based on the following parameters: in eleven cases CD4+ CD8+ cells had an LGL morphology and expressed the CD11b, CD56 and CD57 NK-associated antigens; in addition, a high percentage of CD4+ CD8- cells from the same individuals also expressed NK-associated antigens on their cell surface (subgroup A). The CD4+ CD8+ cells of the remaining individuals had small lymphocyte morphology, expressed little or no CD11b and CD56 and their CD4+ CD8- cells did not express NK-associated antigens at all (subgroup B). Finally, CD8 was "bright" on the CD4+ CD8+ cells of three individuals and in these cells also the CD8 beta chain isoform was present (subgroup C). Southern blot hybridization of genomic DNA with a T-cell receptor beta probe revealed that of the sixteen individuals examined four had a monoclonal, seven an oligoclonal, and five a polyclonal molecular configuration. The present data indicate that persistent CD4+ CD8+ expansions represent a novel heterogeneous subset of T cells.
描述了一组18名个体,其外周血CD4+CD8+T细胞呈现持续性(随访4至57个月)扩增(范围为10%至70%)。9名个体无明显潜在疾病,其余个体则表现出多种不相关疾病。细胞表面免疫表型分析显示,所有个体的CD4+CD8+亚群均高表达CD2、CD3、CD5和TCRα/β。相反,这些细胞不表达CD25、CD38、CD71、HLA-DR和白细胞介素-2受体的β链(p75),但高表达CD29,低表达或不表达CD7。大多数个体的CD8呈“弱阳性”,且仅由CD8α链异构体组成。根据以下参数,这些个体可进一步分为两个亚组:11例中,CD4+CD8+细胞具有大颗粒淋巴细胞(LGL)形态,并表达CD11b、CD56和CD57等自然杀伤(NK)相关抗原;此外,同一批个体中高比例的CD4+CD8-细胞在其细胞表面也表达NK相关抗原(A亚组)。其余个体的CD4+CD8+细胞具有小淋巴细胞形态,很少或不表达CD11b和CD56,其CD4+CD8-细胞根本不表达NK相关抗原(B亚组)。最后,3名个体的CD4+CD8+细胞上的CD8呈“强阳性”,且这些细胞中也存在CD8β链异构体(C亚组)。用T细胞受体β探针进行基因组DNA的Southern印迹杂交显示,在检测的16名个体中,4名具有单克隆分子构型,7名具有寡克隆分子构型,5名具有多克隆分子构型。目前的数据表明,持续性CD4+CD8+扩增代表了一种新型的异质性T细胞亚群。